Published in Pediatr Nephrol on March 11, 2010
Continuous renal replacement therapy in neonates weighing less than 3 kg. Korean J Pediatr (2012) 0.81
Citrate anticoagulation for continuous renal replacement therapy in small children. Pediatr Nephrol (2013) 0.80
Regional citrate anticoagulation in hemodialysis: an observational study of safety, efficacy, and effect on calcium balance during routine care. Can J Kidney Health Dis (2016) 0.76
Alternatives to standard unfractionated heparin for pediatric hemodialysis treatments. Pediatr Nephrol (2012) 0.76
Regional citrate anticoagulation--a safe and effective procedure in pediatric apheresis therapy. Pediatr Nephrol (2010) 0.75
New equations to estimate GFR in children with CKD. J Am Soc Nephrol (2009) 11.48
Activated coagulation time of whole blood. JAMA (1966) 2.36
Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int (1990) 1.48
Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol (2007) 1.39
Regional citrate anticoagulation for hemodialysis in the patient at high risk for bleeding. N Engl J Med (1983) 1.19
Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol (2002) 1.05
Citrate anticoagulation for extracorporeal circuits: effects on whole blood coagulation activation and clot formation. Nephron (2001) 1.05
Pediatric hemofiltration: Normocarb dialysate solution with citrate anticoagulation. Pediatr Nephrol (2002) 0.96
Detection of citrate overdose in critically ill patients on citrate-anticoagulated venovenous haemofiltration: use of ionised and total/ionised calcium. Clin Chem Lab Med (2006) 0.92
Comparison between tinzaparin and standard heparin for chronic hemodialysis in a Canadian center. Am J Nephrol (2002) 0.90
How does warfarin affect the activated coagulation time? Am Heart J (1998) 0.89
Pediatric convective hemofiltration: Normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis (2003) 0.89
A comparison of activated coagulation time-based techniques for anticoagulation during cardiac surgery with cardiopulmonary bypass. J Cardiothorac Vasc Anesth (2007) 0.89
Citrate anticoagulation in pediatric continuous venovenous hemofiltration. Pediatr Nephrol (2003) 0.87
Anticoagulation options for pediatric hemodialysis. Hemodial Int (2003) 0.87
Regional anticoagulation during hemodialysis using citrate. Am J Med Sci (1961) 0.85
Citrate anticoagulation in a piglet model of pediatric continuous renal replacement therapy. Crit Care Med (2002) 0.83
Efficacy and safety of intermittent hemodialysis using citrate as anticoagulant: a prospective study. Clin Nephrol (2007) 0.82
Calcium threshold in human plasma clotting kinetics. Thromb Res (1994) 0.81
[Thrombocytopathy and blood complications in uremia]. Wien Klin Wochenschr (2006) 0.81
The activated coagulation time of whole blood as a routine pre-operative sceening test. Calif Med (1971) 0.79
Citrate anticoagulation control by ionized calcium levels does not prevent hemostasis and complement activation during hemodialysis. Artif Organs (2007) 0.78
Activated clotting time as a screening test prior to catheter-based cardiovascular procedures. Catheter Cardiovasc Interv (2001) 0.78
The activated coagulation time: suitability for monitoring heparin effect and neutralization during pediatric cardiac surgery. J Cardiothorac Vasc Anesth (1996) 0.78
Perioperative coagulation management and blood conservation in cardiac surgery: a Canadian Survey. J Cardiothorac Vasc Anesth (2008) 0.76
Regional citrate anticoagulation for single-needle hemodialysis: a prospective clinical study. Blood Purif (2007) 0.75
An unusual cause of a prolonged activated coagulation time during cardiac surgery: congenital hypofibrinogenemia. J Cardiothorac Vasc Anesth (2007) 0.75
Influence of coagulation parameters on filter running time during continuous venovenous hemofiltration. Contrib Nephrol (1995) 0.75
The approach to anticoagulation in patients treated with extracorporeal therapy in the intensive care unit. Adv Ren Replace Ther (1997) 0.75
Clinical proteomics: A need to define the field and to begin to set adequate standards. Proteomics Clin Appl (2007) 2.84
Exome capture reveals ZNF423 and CEP164 mutations, linking renal ciliopathies to DNA damage response signaling. Cell (2012) 2.54
Early angiotensin-converting enzyme inhibition in Alport syndrome delays renal failure and improves life expectancy. Kidney Int (2011) 2.34
Molecular analysis of the SGLT2 gene in patients with renal glucosuria. J Am Soc Nephrol (2003) 2.34
Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease. Mol Cell Proteomics (2010) 1.90
An outbreak of Shiga toxin-producing Escherichia coli O104:H4 hemolytic uremic syndrome in Germany: presentation and short-term outcome in children. Clin Infect Dis (2012) 1.79
Renal allograft function in matched pediatric and adult recipient pairs of the same donor. Transplantation (2004) 1.55
Urinary proteome analysis identifies infants but not older children requiring pyeloplasty. Pediatr Nephrol (2010) 1.48
Urinary proteome analysis to exclude severe vesicoureteral reflux. Pediatrics (2012) 1.42
Alterations of cyclosporin A metabolism induced by mycophenolate mofetil. Pediatr Transplant (2003) 1.42
Kidney transplant in children weighing less than 15 kg: donor selection and technical considerations. Transplantation (2002) 1.41
Renal arterial resistance index and computerized quantification of fibrosis as a combined predictive tool in chronic allograft nephropathy. Pediatr Transplant (2004) 1.39
Automated Greulich-Pyle bone age determination in children with chronic kidney disease. Pediatr Nephrol (2015) 1.39
Mutations in multiple PKD genes may explain early and severe polycystic kidney disease. J Am Soc Nephrol (2011) 1.38
Demography of pediatric primary care in Europe: delivery of care and training. Pediatrics (2002) 1.34
ANKS6 is a central component of a nephronophthisis module linking NEK8 to INVS and NPHP3. Nat Genet (2013) 1.32
Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome. Nephrol Dial Transplant (2011) 1.24
Schimke immunoosseous dysplasia: suggestions of genetic diversity. Hum Mutat (2007) 1.19
Long-term outcome of renal glucosuria type 0: the original patient and his natural history. Nephrol Dial Transplant (2004) 1.18
Activation of the AKT/mTOR pathway in autosomal recessive polycystic kidney disease (ARPKD). Nephrol Dial Transplant (2009) 1.08
The Cockcroft-Gault formula should not be used in children. Kidney Int (2005) 1.06
Developmental changes in the L-arginine/nitric oxide pathway from infancy to adulthood: plasma asymmetric dimethylarginine levels decrease with age. Clin Chem Lab Med (2007) 1.05
Randomized trial of tacrolimus versus cyclosporin microemulsion in renal transplantation. Pediatr Nephrol (2002) 1.02
Prevention of chronic kidney disease in spina bifida. Int Urol Nephrol (2011) 1.02
Self-adjustment of phosphate binder dose to meal phosphorus content improves management of hyperphosphataemia in children with chronic kidney disease. Nephrol Dial Transplant (2010) 0.99
Management of anemia in children receiving chronic peritoneal dialysis. J Am Soc Nephrol (2013) 0.99
Urinary proteome pattern in children with renal Fanconi syndrome. Nephrol Dial Transplant (2009) 0.98
The bone and mineral disorder of children undergoing chronic peritoneal dialysis. Kidney Int (2010) 0.97
Renal replacement therapy in infants with chronic renal failure in the first year of life. Clin J Am Soc Nephrol (2009) 0.93
Sequential maintenance therapy with cyclosporin A and mycophenolate mofetil for sustained remission of childhood steroid-resistant nephrotic syndrome. Nephrol Dial Transplant (2011) 0.92
Patterns in early diffusion-weighted MRI in children with haemolytic uraemic syndrome and CNS involvement. Eur Radiol (2011) 0.91
Neurological involvement in children with E. coli O104:H4-induced hemolytic uremic syndrome. Pediatr Nephrol (2014) 0.90
Characteristics of early and late PTLD development in pediatric solid organ transplant recipients. Transplantation (2013) 0.89
Glomerular mRNA expression of prothrombotic and antithrombotic factors in renal transplants with thrombotic microangiopathy. Transplantation (2013) 0.89
Generalized atherosclerosis sparing the transplanted kidney in Schimke disease. Pediatr Nephrol (2004) 0.88
Schimke versus non-Schimke chronic kidney disease: an anthropometric approach. Pediatrics (2006) 0.88
Novel findings in patients with primary hyperoxaluria type III and implications for advanced molecular testing strategies. Eur J Hum Genet (2012) 0.88
Early erythropoietin reduced the need for red blood cell transfusion in childhood hemolytic uremic syndrome: a randomized prospective pilot trial. Pediatr Nephrol (2008) 0.87
Advances in urinary proteome analysis and biomarker discovery in pediatric renal disease. Pediatr Nephrol (2009) 0.87
Mycophenolate mofetil versus cyclosporin A in children with frequently relapsing nephrotic syndrome. J Am Soc Nephrol (2013) 0.87
Schimke-immuno-osseous dysplasia: new mutation with weak genotype-phenotype correlation in siblings. Am J Med Genet A (2005) 0.86
Growth and maturation improvement in children on renal replacement therapy over the past 20 years. Pediatr Nephrol (2013) 0.86
mTOR inhibitors in pediatric kidney transplantation. Pediatr Nephrol (2013) 0.86
Growth impairment shows an age-dependent pattern in boys with chronic kidney disease. Pediatr Nephrol (2006) 0.86
Regional citrate anticoagulation is safe in intermittent high-flux haemodialysis treatment of children and adolescents with an increased risk of bleeding. Nephrol Dial Transplant (2010) 0.86
Nephrotic syndrome in African children: lack of evidence for 'tropical nephrotic syndrome'? Nephrol Dial Transplant (2005) 0.85
Computer-assisted quantification of fibrosis in chronic allograft nephropaty by picosirius red-staining: a new tool for predicting long-term graft function. Transplantation (2003) 0.85
Prematurity, small for gestational age and perinatal parameters in children with congenital, hereditary and acquired chronic kidney disease. Nephrol Dial Transplant (2010) 0.84
SMARCAL1 mutations: a cause of prepubertal idiopathic steroid-resistant nephrotic syndrome. Pediatr Res (2009) 0.84
Improved outcome with immunosuppressive monotherapy after renal transplantation in Schimke-immuno-osseous dysplasia. Pediatr Transplant (2008) 0.84
Single centre experience with basiliximab in paediatric renal transplantation. Nephrol Dial Transplant (2002) 0.83
Aetiology and outcome of acute and chronic renal failure in infants. Nephrol Dial Transplant (2008) 0.83
Evaluation of biodegradability of NOM after ozonation. Water Res (2004) 0.83
Cytokine single nucleotide polymorphisms and intrarenal gene expression in chronic allograft nephropathy in children. Kidney Int (2003) 0.83
Diagnostic pathways for exclusion and diagnosis of kidney diseases. Clin Lab (2012) 0.82
Longitudinal growth on an everolimus- versus an MMF-based steroid-free immunosuppressive regimen in paediatric renal transplant recipients. Transpl Int (2013) 0.82
Young for young! Mandatory age-matched exchange of paediatric kidneys. Pediatr Nephrol (2006) 0.81
Comparing cystatin C and creatinine in the diagnosis of pediatric acute renal allograft dysfunction. Pediatr Nephrol (2011) 0.81
Thirty years of the Union of National European Paediatric Societies and Associations (UNEPSA). Eur J Pediatr (2006) 0.81
Pediatric kidney transplantation followed by de novo therapy with everolimus, low-dose cyclosporine A, and steroid elimination: 3-year data. Transplantation (2011) 0.81
Renal arterial resistance index. N Engl J Med (2003) 0.81
Elevated asymmetric dimethylarginine (ADMA) and inverse correlation between circulating ADMA and glomerular filtration rate in children with sporadic focal segmental glomerulosclerosis (FSGS). Nephrol Dial Transplant (2008) 0.81
B cell depletion for autoimmune diseases in paediatric patients. Clin Rheumatol (2010) 0.81
Comprehensive analysis of glomerular mRNA expression of pro- and antithrombotic genes in atypical haemolytic-uremic syndrome (aHUS). Virchows Arch (2013) 0.80
Growth hormone treatment of renal growth failure during infancy and early childhood. Pediatr Nephrol (2009) 0.80
Early kidney transplantation improves neurocognitive outcome in patients with severe congenital chronic kidney disease. Transpl Int (2015) 0.79
Quantitative gene expression of TGF-beta1, IL-10, TNF-alpha and Fas Ligand in renal cortex and medulla. Nephrol Dial Transplant (2002) 0.79
Haemorrhagic complications in paediatric dialysis-dependent acute kidney injury: Incidence and impact on outcome. Nephrol Dial Transplant (2009) 0.79
Paediatric kidney transplantation in small children-- a single centre experience. Transpl Int (2006) 0.78
Advantages of cyclosporin A using 2-h levels in pediatric kidney transplantation. Pediatr Nephrol (2004) 0.78
Increased asymmetric dimethylarginine (ADMA) dimethylaminohydrolase (DDAH) activity in childhood hypercholesterolemia type II. Amino Acids (2011) 0.78
Impact of 6% hydroxyethyl starch 130/0.42 and 4% gelatin on renal function in a pediatric animal model. Paediatr Anaesth (2014) 0.78
Reliability of different expert systems for profiling proteinuria in children with kidney diseases. Pediatr Nephrol (2007) 0.78
Corticosteroid-resistant nephrotic syndrome with focal and segmental glomerulosclerosis : an update of treatment options for children. Paediatr Drugs (2008) 0.77
Effective treatment of anemia in pediatric kidney transplant recipients with methoxy polyethylene glycol-epoetin beta. Pediatr Transplant (2011) 0.77
Estimation of glomerular filtration rate in liver-transplanted children: comparison of simplified procedures using 51Cr-EDTA and endogenous markers with Sapirstein's method as a reference standard. Pediatr Transplant (2010) 0.77
Efficacy and safety of basiliximab in pediatric renal transplant patients receiving cyclosporine, mycophenolate mofetil, and steroids. Transplantation (2008) 0.77
Acute and chronic antibody-mediated rejection in pediatric kidney transplantation. Pediatr Nephrol (2014) 0.77